Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Beilu Pharma(300016) the Revenue is 352.96 M (+17.06%);the EBIT is 49.25 M (+78.78%);the EPS is 0.0603 (+100.9%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.35B17.06%
----
----
EBIT
0.05B78.78%
----
----
EPS
0.0603100.86%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf